Melatonin therapy in patients with Alzheimer's disease
Abstract: Alzheimer’s disease (AD) is a major health problem and a growing recognition exists that efforts to prevent it must be undertaken by both governmental and non-governmental organizations. In this context, the pineal product, melatonin, has a promising significance because of its chronobioti...
Guardado en:
| Autores principales: | Cardinali, Daniel Pedro, Vigo, Daniel Eduardo, Olivar, Natividad, Vidal, María Florencia, Brusco, Luis I. |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés Inglés |
| Publicado: |
MDPI AG
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/1647 |
| Aporte de: |
Ejemplares similares
-
Therapeutic application of melatonin in mild cognitive impairment
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
An exploratory study of sleep-wake differences of autonomic activity in patients with mild cognitive impairment : the role of melatonin as a modulating factor
por: Abulafia, Carolina Andrea, et al.
Publicado: (2023) -
Therapeutical implications of melatonin in alzheimer’s and parkinson’s diseases
por: Cardinali, Daniel Pedro, et al.
Publicado: (2020) -
Melatonin as a chronobiotic/cytoprotector : its role in healthy aging
por: Cardinali, Daniel Pedro
Publicado: (2020) -
Clinical aspects of melatonin intervention in Alzheimer's disease progression
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)